State Getting $7.5M Settlement From Opioid Addiction Treatment Producer
In 2016, Wisconsin joined an anti-trust lawsuit against Indivior, the maker of a drug used to treat opioid addiction called Suboxone.
![Pills by Tom Varco (Own work) [CC BY-SA 3.0 (http://creativecommons.org/licenses/by-sa/3.0)], via Wikimedia Commons.](https://urbanmilwaukee.com/wp-content/uploads/2016/11/1024px-Lexapro_pills.jpg)
Pills by Tom Varco (Own work) (CC BY-SA 3.0), via Wikimedia Commons.
In 2016, Wisconsin’s then-Attorney General Brad Schimel led 41 states and the District of Columbia in filing a federal lawsuit against Indivior, which makes Suboxone.
The anti-trust lawsuit claimed the pharmaceutical company used illegal means to try and preserve its drug monopoly, so it could stifle generic competition and inflate prices. It alleged the company switched the Suboxone market from tablets to a type of film that dissolves on the tongue, while at the same time it tried to destroy the market for tablets.
In all, the states are set to get $102.5 million total from the settlement agreement, which was announced Friday and still needs to be approved by a U.S. District Court judge in the Eastern District of Pennsylvania.
“We take our role as a responsible steward of medications for addiction and rescue extremely seriously,” Indivior’s CEO Mark Crossley said in a statement about the settlement. “Resolving these legacy matters at the right value allows us to further this mission for patients.”
As part of the settlement, Invidior agreed to notify the participating states about the introduction of new products, changes in corporate counsel or any citizen petitions to the U.S. Food and Drug Administration.
Those stipulations “will help the States ensure that Indivior refrains from engaging in the same kind of conduct alleged in the complaint,” according to a news release from the Wisconsin Department of Justice.
Suboxone is prescribed to prevent opioid overdose, reduce cravings and treat withdrawal symptoms.
For help with recovery from addiction, call the free and confidential treatment referral hotline (1-800-662- HELP), or visit findtreatment.gov.
Listen to the WPR report here.
Wisconsin poised to get $7.5M from lawsuit against maker of medication used to treat opioid abuse was originally published by Wisconsin Public Radio.
More about the Opioid Crisis
- Serenity Inns Opens New Addiction Treatment Center in Milwaukee - Serenity Inns - Aug 14th, 2024
- MKE County: County Nearly Doubles Narcan Vending Machines - Graham Kilmer - Aug 12th, 2024
- Milwaukee County Executive David Crowley Announces Placement of Eight Additional Harm Reduction Vending Machines - County Executive David Crowley - Aug 12th, 2024
- Milwaukee’s Native Community Faces Surge in Opioid Deaths - Trisha Young - Jul 8th, 2024
- MKE County: County Awards $2.8 Million To Non-Profit Opioid Programs - Graham Kilmer - Jul 2nd, 2024
- MKE County: County To Get $3 Million From Kroger In Opioid Settlement - Graham Kilmer - Jul 1st, 2024
- Court Decision Holds Up Wisconsin’s $70 Million Drug Settlement - Sarah Lehr - Jul 1st, 2024
- MKE County: Opioid Settlement Will Fund 7 New, Expanded Abatement Efforts - Graham Kilmer - Jun 28th, 2024
- Legislators Agree on Opioid Plan, Still Withhold PFAS, Hospital Funds - Erik Gunn - May 8th, 2024
- Baldwin Announces Over $17.7 Million to Tackle Fentanyl and Opioid Crisis in Wisconsin - U.S. Sen. Tammy Baldwin - May 7th, 2024
Read more about Opioid Crisis here